journal article·2022-01Open access

The fabrication of halloysite nanotube-based multicomponent hydrogel scaffolds for bone healing

Saeideh Same, Jamileh Kadkhoda, Golnaz Navidi, Fatemeh Abedi, Marziyeh Aghazadeh, Morteza Milani, Abolfazl Akbarzadeh, Soodabeh Davaran

Abstract

Bone tissue engineering, as an alternative for common available therapeutic approaches, has been developed to focus on reconstructing of the missing tissues and restoring their functionality. In this work, three-dimensional (3D) nanocomposite scaffolds of polycaprolactone-polyethylene glycol-polycaprolactone/gelatin (PCEC/Gel) were prepared by freeze-drying method. Biocompatible nanohydroxyapatite (nHA), iron oxide nanoparticle (Fe 3 O 4 ) and halloysite nanotube (HNT) powders were added to the polymer matrix aiming to combine the osteogenic activity of nHA or Fe 3 O 4 with high mechanical strength of HNT. The scanning electron microscope (SEM) methods was utilized to characterize the nanotube morphology of HNT as well as nanoparticles of Fe 3 O 4 and nHA. Prepared scaffolds were characterized via Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction analysis (XRD), and SEM methods. In addition, the physical behavior of scaffolds was evaluated to explore the influence of HNT on the physicochemical properties of composites. Cell viability and attachment were investigated by MTT (3-(4,5-dimethylthiazol-2-yl)−2,5-diphenyl-2H-tetrazolium bromide) assay and SEM on human dental pulp-derived mesenchymal stem cells (h-DPSCs) in-vitro. Cell proliferation was observed without any cytotoxicity effect on h-DPSCs for all examined scaffolds. Alizarin red (ARS) and alkaline phosphatase (ALP) staining were carried out to determine the osteoconductivity of scaffolds. The data demonstrated that all PCEC/Gel/HNT hydrogel scaffolds supported osteoblast differentiation of hDPSCs with moderate effects on cell proliferation. Moreover, PCEC/Gel/HNT/nHA with proper mechanical strength showed better biological activity compared to PCEC/Gel/HNT/Fe 3 O 4 and PCEC/Gel/HNT scaffolds. Therefore, this study suggested that with proper fillers content, PCEC/Gel/HNT nanocomposite hydrogels alone or in a complex with nHA, Fe 3 O 4 could be a suitable candidate for hard tissue regeneration.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Therapeutic Uses of Natural Elements · Bone Tissue Engineering Materials · Clay minerals and soil interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran

Drug Applied Research Center, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

Organosilicon Research Laboratory, Faculty of Chemistry, University of Tabriz, Tabriz, Iran

Clinical Research Development, Unit of Tabriz Valiasr Hospital, Tabriz University of Medical Sciences, Tabriz, Iran

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Faculty of Advanced Medical Science, Tabriz University of Medical Sciences, Tabriz, Iran

Department of Medicinal Chemistry, Faculty of Pharmacy, Tabriz University of Medical Science, Tabriz, Iran

Funding

research center for pharmaceutical nanotechnology

References (50)

Show source-provided references
1. 10.1016/j.compscitech.2020.10856310.1016/j.compscitech.2020.108563 ↗
2. 10.1016/j.colsurfb.2018.09.04510.1016/j.colsurfb.2018.09.045 ↗
3. 10.1007/s11706-014-0232-110.1007/s11706-014-0232-1 ↗
4. 10.1021/acsbiomaterials.9b0027710.1021/acsbiomaterials.9b00277 ↗
5. 10.1021/acsomega.8b0259310.1021/acsomega.8b02593 ↗
6. 10.1177/088532822199852510.1177/0885328221998525 ↗
7. 10.1155/2019/747205810.1155/2019/7472058 ↗
8. 10.1039/D0BM01840F10.1039/D0BM01840F ↗
9. 10.1007/s10856-013-5071-610.1007/s10856-013-5071-6 ↗
10. 10.15171/apb.2016.04710.15171/apb.2016.047 ↗
11. 10.1039/C9RA08366A10.1039/C9RA08366A ↗
12. 10.3390/polym1209204510.3390/polym12092045 ↗
13. 10.1002/masy.20200031410.1002/masy.202000314 ↗
14. 10.1002/jbm.a.3663310.1002/jbm.a.36633 ↗
15. 10.3390/ijms2301018810.3390/ijms23010188 ↗
16. 10.1038/s41598-020-58738-510.1038/s41598-020-58738-5 ↗
17. 10.1021/acsomega.8b0029110.1021/acsomega.8b00291 ↗
18. 10.3390/app1201009510.3390/app12010095 ↗
19. 10.1039/D0BM00906G10.1039/D0BM00906G ↗
20. Lin J · Curr Adv Cell Stem Cell · 2017 · 1 · 101011
21. 10.1016/j.apsusc.2020.14577210.1016/j.apsusc.2020.145772 ↗
22. 10.1007/s10853-021-06145-010.1007/s10853-021-06145-0 ↗
23. 10.1016/j.colsurfb.2020.11094410.1016/j.colsurfb.2020.110944 ↗
24. 10.1080/09205063.2018.144762710.1080/09205063.2018.1447627 ↗
25. 10.1007/s13770-018-0140-z10.1007/s13770-018-0140-z ↗
26. 10.1016/j.actbio.2016.09.02010.1016/j.actbio.2016.09.020 ↗
27. 10.2174/1574888X1566620010112250510.2174/1574888X15666200101122505 ↗
28. 10.1016/j.msec.2017.02.08710.1016/j.msec.2017.02.087 ↗
29. 10.3390/ma1010112310.3390/ma10101123 ↗
30. 10.1016/j.bioactmat.2020.09.03110.1016/j.bioactmat.2020.09.031 ↗
31. 10.3390/coatings1010094410.3390/coatings10100944 ↗
32. 10.1177/088532821668015210.1177/0885328216680152 ↗
33. Luo Y. · 2019
34. 10.1016/j.msec.2019.04.01210.1016/j.msec.2019.04.012 ↗
35. 10.1177/088532821882264110.1177/0885328218822641 ↗
36. 10.1002/jbm.a.3695010.1002/jbm.a.36950 ↗
37. 10.1016/j.ijbiomac.2019.04.00510.1016/j.ijbiomac.2019.04.005 ↗
38. 10.1002/jbm.a.3680610.1002/jbm.a.36806 ↗
39. 10.2147/IJN.S21388910.2147/IJN.S213889 ↗
40. 10.1016/j.msec.2019.11007210.1016/j.msec.2019.110072 ↗
41. 10.1039/C5TB00118H10.1039/C5TB00118H ↗
42. 10.1016/j.cej.2019.12301910.1016/j.cej.2019.123019 ↗
43. 10.1016/j.msec.2018.05.03310.1016/j.msec.2018.05.033 ↗
44. 10.1088/1748-605X/ab007b10.1088/1748-605X/ab007b ↗
45. 10.1021/nn506255e10.1021/nn506255e ↗
46. 10.1002/pen.2451210.1002/pen.24512 ↗
47. 10.1016/j.msec.2016.11.04910.1016/j.msec.2016.11.049 ↗
48. 10.1002/adhm.20200031810.1002/adhm.202000318 ↗
49. 10.1016/j.matdes.2019.10827510.1016/j.matdes.2019.108275 ↗
50. 10.1186/s12951-021-00958-610.1186/s12951-021-00958-6 ↗